CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
about
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaCoregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3.Role of mesenchymal cells in the natural history of ovarian cancer: a reviewTranscriptional regulation of chemokine expression in ovarian cancerChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsThe Role of CC-Chemokines in the Regulation of AngiogenesisTargeted immune therapy of ovarian cancerThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentOrchestration of angiogenesis by immune cellsInflammation and the two-hit hypothesis of schizophrenia.Sustained delivery of a HIF-1 antagonist for ocular neovascularization.Chemotaxis in cancerMicrofluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells.Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma.The biology of ovarian cancer: new opportunities for translationHypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.CXCL12 expression by healthy and malignant ovarian epithelial cells.Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.The role of chemoattractant receptors in shaping the tumor microenvironment.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsPromoted Growth of Brain Tumor by the Transplantation of Neural Stem/Progenitor Cells Facilitated by CXCL12.Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer.Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cellsCXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma.Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.Heterogeneity of functional properties of Clone 66 murine breast cancer cells expressing various stem cell phenotypesGene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasisAnti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancerT(H)17 cells in tumour immunity and immunotherapy.T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4Expression of SDF-1α and leptin, and their effect on expression of angiogenic factors in mouse ovaries.The aortic ring model of angiogenesis: a quarter century of search and discovery.
P2860
Q24676809-7B68C067-A6A3-47A5-922B-7306E68A513FQ24682828-5C65A6AE-EC52-4DAB-A778-105A0C74DD5EQ26823555-072E062A-3C3F-4B68-B6A8-264229667A2CQ26825361-68CF4A34-37C5-4783-83AC-84C7794AA473Q26830743-917F642F-9CA1-49EB-BD81-D159C0252E5CQ28075712-404EB8F5-4ADE-4ED8-8966-BD1B52B2684AQ28077024-AB56DF03-FA59-4A0F-A5A1-17ACA09A20E2Q28082828-7ACA639C-8E74-465E-871E-14E1851165DDQ28241308-923BB6FE-FAD7-4CB7-8F6A-D2D775C83C75Q28389236-551E382C-2B2C-4BDD-9662-73CBA7E02072Q30422062-AB0A08EE-F3F6-43C9-86CA-4FBBC4D56920Q30560557-9FD14DC3-748C-4EAC-BFB3-4F2601B05E58Q30578627-045BF8D2-A9A6-4F0C-A23D-71BDA3F07145Q33457167-0A7FAB6D-168D-4400-8458-27A604DF6899Q33609069-47B141B9-C257-40E5-BABC-B74376E369D8Q33622369-13D4C845-62A8-4BBD-9490-EE66B4B9CFB7Q33829094-48B460C4-8C46-4CF7-9521-506037C4EFD4Q33848551-616BBC34-CF01-489D-BD82-57190864FDF4Q33959320-B805BA30-962F-4D54-B083-CDCB9D6F4003Q33993124-D86480B9-844E-4230-8266-88B945F80499Q34021737-DE612F8A-C6A0-4539-A86B-2ACCD728D288Q34092169-98EE2AEB-E791-4455-A91C-309B7CEED7FCQ34321219-0E95CA14-944D-40E8-878B-0753B9C870AAQ34391785-743B94CA-DDAB-48A4-8CED-6FA5C5E2B914Q34471954-97756BDA-3111-4B95-A4DD-43469B80E94EQ34476278-2499DCEC-BBE1-48AB-AAD3-C0155059212CQ34570835-0797667A-FDA0-42BE-A8F0-189DE7AB4FCCQ34617035-E47B64C2-41A9-479B-8E5F-586C169B43B2Q34649455-7C05A7C9-C71C-43AB-B795-3AE3EEB1CE30Q34810458-24A60562-DDD7-4C94-8381-5A23CEFE8548Q34983123-72F0B2AF-ABD3-43DE-802B-627241268404Q35050347-DF6A4171-55B8-4119-A640-500E97E37D32Q35146386-5633EA59-FEAF-4CE6-953C-DE8E77FA8AF2Q35205410-F2C4CA7A-9D66-48A3-AD2B-48372498A1CEQ35604189-0AAFF102-B30D-47D0-BEC0-755BCFEF2954Q35623903-30182C4A-3089-413F-85D9-A11C34F726F8Q35632079-62D76166-4AD6-4D43-9DCB-64954DE90237Q35669726-B395F328-C5E9-451C-A03D-97F56B9195EBQ35767839-732D1932-B8CD-45B0-BBA4-86CB40F63C2AQ35832019-16AA3116-9BB0-4F37-ADF2-5E85A7B4FF36
P2860
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
CXCL12 and vascular endothelia ...... esis in human ovarian cancers.
@en
CXCL12 and vascular endothelia ...... esis in human ovarian cancers.
@nl
type
label
CXCL12 and vascular endothelia ...... esis in human ovarian cancers.
@en
CXCL12 and vascular endothelia ...... esis in human ovarian cancers.
@nl
prefLabel
CXCL12 and vascular endothelia ...... esis in human ovarian cancers.
@en
CXCL12 and vascular endothelia ...... esis in human ovarian cancers.
@nl
P2093
P1433
P1476
CXCL12 and vascular endothelia ...... nesis in human ovarian cancers
@en
P2093
Andrew Lackner
Dominique Emilie
Ilona Kryczek
Lieve Moons
Linhua Zou
Margarita Terrassa
Melina Hogan
Peter Carmeliet
Peter Mottram
P304
P407
P50
P577
2005-01-01T00:00:00Z